These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 33153099)

  • 1. Pharmaceutical Excipients and Drug Metabolism: A Mini-Review.
    Patel R; Barker J; ElShaer A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation of in vitro cytochrome p450 activity by common pharmaceutical excipients.
    Martin P; Giardiello M; McDonald TO; Rannard SP; Owen A
    Mol Pharm; 2013 Jul; 10(7):2739-48. PubMed ID: 23701529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.
    Zhang W; Li Y; Zou P; Wu M; Zhang Z; Zhang T
    AAPS J; 2016 Jul; 18(4):830-43. PubMed ID: 27184579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of excipients on transporter mediated absorption.
    Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
    Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration.
    Ren X; Mao X; Si L; Cao L; Xiong H; Qiu J; Schimmer AD; Li G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):279-88. PubMed ID: 18499414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 Enzymes and Drug Metabolism in Humans.
    Zhao M; Ma J; Li M; Zhang Y; Jiang B; Zhao X; Huai C; Shen L; Zhang N; He L; Qin S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An accurate and precise representation of drug ingredients.
    Hanna J; Bian J; Hogan WR
    J Biomed Semantics; 2016; 7():7. PubMed ID: 27096073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactions.
    Lu C; Liao M; Cohen L; Xia CQ
    Curr Drug Discov Technol; 2010 Sep; 7(3):199-222. PubMed ID: 20843292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 model.
    Shah D; Paruchury S; Matta M; Chowan G; Subramanian M; Saxena A; Soars MG; Herbst J; Haskell R; Marathe P; Mandlekar S
    Drug Metab Lett; 2014; 8(2):109-18. PubMed ID: 25429513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of pharmaceutical excipients on drug disposition.
    Buggins TR; Dickinson PA; Taylor G
    Adv Drug Deliv Rev; 2007 Dec; 59(15):1482-503. PubMed ID: 18198495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies.
    Constantinides PP; Wasan KM
    J Pharm Sci; 2007 Feb; 96(2):235-48. PubMed ID: 17051593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.
    Decleves X; Jacob A; Yousif S; Shawahna R; Potin S; Scherrmann JM
    Curr Drug Metab; 2011 Oct; 12(8):732-41. PubMed ID: 21623707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro.
    Gurjar R; Chan CYS; Curley P; Sharp J; Chiong J; Rannard S; Siccardi M; Owen A
    Mol Pharm; 2018 Nov; 15(11):4835-4842. PubMed ID: 30350641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of excipient interactions on drug bioavailability from solid dosage forms.
    Panakanti R; Narang AS
    Pharm Res; 2012 Oct; 29(10):2639-59. PubMed ID: 22610283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Pharmaceutical Excipients on Intestinal Absorption of Metformin via Organic Cation-Selective Transporters.
    Ruan Y; Li X; You L; Chen J; Shen Y; Zhang J; Yuan Y; Kang L; Qin C; Wu C
    Mol Pharm; 2021 Jun; 18(6):2198-2207. PubMed ID: 33956455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of potential herb-drug interactions based on the effect of Suxiao Jiuxin Pill on CYP450 enzymes and transporters.
    Qiang T; Li Y; Wang K; Lin W; Niu Z; Wang D; Wang X
    J Ethnopharmacol; 2021 Nov; 280():114408. PubMed ID: 34252529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
    Verbeeck RK
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on cytochrome P450-mediated cardiovascular drug interactions.
    Cheng JW; Frishman WH; Aronow WS
    Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.